Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gudrun Göhring

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Stem Cell Research|July 6, 2017
Generation of non-transgenic iPS cells from human cord blood CD34<sup>+</sup> cells under animal component-free conditionsAlexandra Haase, Gudrun Göhring, Ulrich Martin
American Journal of Stem Cells|May 15, 2013
Genetic instability of modified stem cells - a first step towards malignant transformation?Doris Steinemann, Gudrun Göhring, Brigitte Schlegelberger
Leukemia & Lymphoma|September 1, 2011
Update on cytogenetic and molecular changes in myelodysplastic syndromesBrigitte Schlegelberger, Gudrun Göhring, Felicitas Thol, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Concise review: managing genotoxicity in the therapeutic modification of stem cellsChristopher Baum, Ute Modlich, Gudrun Göhring, et al.
Leukemia Research|December 22, 2009
Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH studyKathrin Lange, Dorothea Gadzicki, Brigitte Schlegelberger, et al.
Fetal Diagnosis and Therapy|October 4, 2008
Prenatal diagnosis of an epignathus associated with a 49,XXXXY karyotype--a case reportIsmini Staboulidou, Konstantin Miller, Gudrun Göhring, et al.
Journal of Pediatric Surgery|October 31, 2002
MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitroSteven Warmann, Gudrun Göhring, Birgit Teichmann, et al.
Cancer Genetics|April 11, 2013
Myelofibrosis in Philadelphia chromosome-negative myeloproliferative neoplasms is associated with aberrant karyotypesGesa Hauck, Danny Jonigk, Gudrun Göhring, et al.
Stem Cell Research|September 20, 2017
Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODNSylvia Merkert, Christien Bednarski, Gudrun Göhring, et al.
Stem Cell Research|April 12, 2017
Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1Sabine Jung-Klawitter, Juliane Ebersold, Gudrun Göhring, et al.
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Stem Cell Research|July 6, 2017
Generation of non-transgenic iPS cells from human cord blood CD34<sup>+</sup> cells under animal component-free conditionsAlexandra Haase, Gudrun Göhring, Ulrich Martin
American Journal of Stem Cells|May 15, 2013
Genetic instability of modified stem cells - a first step towards malignant transformation?Doris Steinemann, Gudrun Göhring, Brigitte Schlegelberger
Leukemia & Lymphoma|September 1, 2011
Update on cytogenetic and molecular changes in myelodysplastic syndromesBrigitte Schlegelberger, Gudrun Göhring, Felicitas Thol, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Concise review: managing genotoxicity in the therapeutic modification of stem cellsChristopher Baum, Ute Modlich, Gudrun Göhring, et al.
Leukemia Research|December 22, 2009
Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH studyKathrin Lange, Dorothea Gadzicki, Brigitte Schlegelberger, et al.
Fetal Diagnosis and Therapy|October 4, 2008
Prenatal diagnosis of an epignathus associated with a 49,XXXXY karyotype--a case reportIsmini Staboulidou, Konstantin Miller, Gudrun Göhring, et al.
Journal of Pediatric Surgery|October 31, 2002
MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitroSteven Warmann, Gudrun Göhring, Birgit Teichmann, et al.
Cancer Genetics|April 11, 2013
Myelofibrosis in Philadelphia chromosome-negative myeloproliferative neoplasms is associated with aberrant karyotypesGesa Hauck, Danny Jonigk, Gudrun Göhring, et al.
Stem Cell Research|September 20, 2017
Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODNSylvia Merkert, Christien Bednarski, Gudrun Göhring, et al.
Stem Cell Research|April 12, 2017
Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1Sabine Jung-Klawitter, Juliane Ebersold, Gudrun Göhring, et al.
Pageof 18